[A hormonal drug melatonin in the treatment of cognitive function disorders in parkinsonism].
作者信息
Arushanian E B
出版信息
Eksp Klin Farmakol. 2010 Mar;73(3):35-9.
PMID:20408429
Abstract
Pineal hormone melatonin, which is known to possess neuroptotector and nootrope activity, also produces a significant therapeutic effect with respect to various brain pathologies. The review of original and published data suggests that it is expedient to use melatonin in the treatment of cognitive disorders accompanying Parkinson's disease.
摘要
相似文献
1
[A hormonal drug melatonin in the treatment of cognitive function disorders in parkinsonism].
Eksp Klin Farmakol. 2010 Mar;73(3):35-9.
2
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
J Neurosci Res. 2010 Feb 1;88(2):420-7. doi: 10.1002/jnr.22201.
3
[Epiphyseal hormone melatonin: a new nootrope?].
Eksp Klin Farmakol. 2005 May-Jun;68(3):74-9.
4
Drugs for cognitive loss and dementia.
Treat Guidel Med Lett. 2010 Mar;8(91):19-24.
5
Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.
Funct Neurol. 1997 May-Aug;12(3-4):211-2.
6
A case study in the treatment of dementia with Lewy bodies.
Acta Psychiatr Scand. 2004 Jul;110(1):73-5; discussion 75-6. doi: 10.1111/j.1600-0447.2004.00323.x.
7
Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.
Pharmacol Biochem Behav. 2005 Jan;80(1):9-26. doi: 10.1016/j.pbb.2004.10.022. Epub 2004 Dec 15.
8
Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
Int J Geriatr Psychiatry. 2003 Oct;18(10):937-41. doi: 10.1002/gps.949.
9
Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
Funct Neurol. 1997 May-Aug;12(3-4):221-5.
10
Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Neurobiol Dis. 2006 May;22(2):421-34. doi: 10.1016/j.nbd.2005.12.008. Epub 2006 Feb 9.
引用本文的文献
1
Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.
Curr Neuropharmacol. 2020;18(7):563-577. doi: 10.2174/1570159X18666191230114339.
Zotero 插件